Table 1.
Description the studies discussed in this review.
| Reference | Intervention | Participants | Sample size |
Study design | Control group(s) |
Measurement type* |
Pain | Measurement outcomes |
Effect size for Pain intensity outcome (Hedges’ g)† |
|---|---|---|---|---|---|---|---|---|---|
| Ambron et al. (2018)1 | VR | Phantom limb pain patients | n = 2 | Case study | n/a | Subjective | Intensity | Numerical pain scale (NRS) | Missing data |
| Carrougher et al. (2009)5 | VR | Burn injuries patients | n = 39 | Within-subjects | One session w/VR, one session w/out VR (order counterbalanced) | Subjective | Intensity (worst pain), time spent thinking about pain, unpleasantness, and opioid equivalents | Graphic rating scale (GRS) | GRS, worst pain: 0.536 Opioid equivalents: −0.171 |
| Demeter et al. (2015)11 | VR | Healthy participants | n = 62 | Within-subjects | Baseline, tonic noxious heat stimulation only | Subjective and objective | Intensity and threshold | NPS, latency of intolerability, temperature at which pain was first perceived, and thermal sensory analyzer (TSA) | NPS heat intensity: −0.671 |
| Ford et al. (2018)15 | VR | Burn injury patients | n = 10 | Observational study | n/a | Subjective | Intensity | Satisfaction questionnaire (no pain ratings) | Missing data/ |
| Gutierrez-Maldonado et al. (2012)25 | VR | Healthy participants | n = 45 | Within-subjects | No VR | Subjective | Threshold, tolerance, intensity, self-efficacy, and catastrophizing | Pain Catastrophizing Scale (PCS) and Visual Analogue Scale (VAS) | Strongest pain intensity: −0.126 |
| Hoffman et al. (2000)27 | VR | Burn injury patients | n = 2 | Within-subjects | Videogame only during wound care | Subjective | Intensity | VAS | Missing data |
| Hoffman et al. (2000)28 | VR | Burn injury patients | n = 12 | Within-subjects | Control condition: no distraction during physical therapy | Subjective | Intensity | VAS | Average pain: −1.12 Worst pain: −1.11 |
| Hoffman et al. (2004)30 | VR | Healthy participants | n = 8 | Within-subjects | No VR during thermal stimuli | Subjective and objective | Intensity (time spent thinking about pain, unpleasantness, worst pain, amount of fun, amount of nausea, and presence) | GRS and fMRI | Missing data |
| Hoffman et al. (2004)33 | VR | Healthy participants | n = 39 | Between-subjects | Low-tech VR | Subjective | Cognitive, sensory, and affective components of pain | Rankings from 0-10 | −1.49 |
| Hoffman et al. (2006)32 | VR | Healthy participants | n = 77 | Between-subjects | No distraction | Subjective | Cognitive, affective, and sensory components of pain | Rankings from 0-10 | Missing data |
| Hoffman et al. (2007)31 | VR | Healthy participants | n = 9 | Within-subjects | No analgesia, opioids | Subjective, objective | Intensity | GRS, blood oxygen level–dependent assessments of brain activity (fMRI) | Worst pain intensity VR–/opioid– vs VR+/opioid–: –1.32 VR–/opioid– vs VR–/opioid+: −0.367 VR–/opioid– vs VR+/opioid+: −2.46 |
| Hoffman et al. (2008)29 | VR | Burn injury patients | n = 11 | Within-subjects | No VR during wound care | Subjective | Worst pain, pain unpleasantness, time spent thinking about pain, and fun | GRS | Worst pain: −1.05 Unpleasant: −1.09 |
| Jeffs et al. (2014)37 | VR | Burn injury patients | n = 30 | Between-subjects | Passive distraction and standard care | Subjective | Intensity | Adolescent pediatric pain tool | Missing data |
| Jin et al. (2016)39 | VR | Chronic pain patients | n = 20 | Within-subjects | Self-mediated session (regular distracting activities) | Subjective | Intensity | VAS | −0.96 |
| Johnson et al. (2016)40 | VR | Healthy participants | n = 32 | Within-subjects | Baseline (no sound, no VR), sound only | Objective | Tolerance | Pain tolerance times | Sound only vs baseline: 0.293†† Head mounted device (HMD) only vs baseline: 1.01†† HMD + sound vs baseline: 1.01†† HMD + sound vs sound only: 0.941†† HMD + sound vs HMD only: 0.430†† |
| Jones et al. (2016)41 | VR | Chronic pain patients | n = 30 | Within-subjects | n/a (pre–post pain scores) | Subjective | Intensity | NRS | −0.741 |
| Kipping et al. (2012)44 | VR | Burn injuries patients | n = 41 | Between-subjects | Distraction | Subjective, objective | Intensity | VAS, heart rate (HR), oxygen saturation (OS) | Subject VAS, dressing removal: −0.465 Subject VAS, dressing application: −0.420 |
| Loreto-Quijada et al. (2014)50 | VR | Healthy participants | n = 77 | Between-subjects | No VR | Subjective, objective | Intensity, tolerance, threshold, time perception, and pain sensitivity range | VAS, PCS | Missing data |
| Maani et al. (2011)52 | VR | Burn injury patients | n = 2 | Case study | n/a | Subjective | Intensity/unpleasantness | GRS | Missing data |
| Maani et al. (2011)53 | VR | Burn injury patients | n = 12 | Within-subjects | No distraction during wound care | Subjective | Intensity/unpleasantness | GRS | Worst pain ≥7: Worst pain: −1.331‡‡ Unpleasantness: −2.13‡‡ Time thinking about pain: −2.44‡‡ Worst pain <7: Worst pain: −0.40‡‡ Unpleasantness: −0.75‡‡ Time thinking about pain: −1.79‡‡ |
| Sano et al. (2015)73 | VR | Phantom limb pain patients | n = 6 | Within-subjects | n/a | Subjective | Pain total score (sensory and affective components) | Short Form McGill Pain Questionnaire | −0.230 |
| Schmitt et al. (2011)75 | VR | Burn injury patients | n = 54 | Within-subjects | No VR | Subjective | Sensory, affective, and cognitive components | GRS | −0.516 |
| Smith et al. (2017)80 | VR | Healthy participants | n = 25 | Within-subjects | Neutral, pleasant, threatening, socially positive, and socially negative contexts | Subjective, objective | Intensity (threshold) | Pressure pain thresholds (PPTs) and PCS | Missing data |
| Sulea et al. (2014)81 | VR | Healthy participants | n = 6 | Within-subjects | No VR | Subjective | Intensity | “Perceived level of pain on a 0-10 scale” | Missing data |
| Wiederhold et al. (2014)86 | VR | Chronic pain patients | n = 40 | Within-subjects | Pain focus condition | Subjective and objective | Intensity | HR, skin temperature, “self-report questionnaires… on a scale of 1 to 7” | Mean pain rating: −0.848 (pilot cohort) |
| Bradt et al. (2015)4 | Music therapy (MT), music medicine (MM) | Cancer pain patients | n = 31 | Between-subjects | n/a | Subjective | Intensity | NRS | MT, pre-therapy to post-therapy: −0.366 MM, pre-therapy to post-therapy: −0.450 MT vs MM: 0 |
| Colwell et al. (2013)10 | MT, MM | Hospitalized pain children | n = 32 | Between-subjects | n/a | Subjective, objective | Pain/anxiety | HR, blood pressure (BP), OS, Wong-Baker FACES Pain Rating Scale | Pain rating score, post-treatment: Music listening vs music composition: 0.21 Music listening vs Orff-based: 0 Music composition vs Orff-based: −0.18 |
| Mondanaro et al. (2017)63 | MT | Postspine surgery pain patients | n = 60 | Between-subjects | Standard care | Subjective | Intensity | VAS | VAS, MT preintervention vs postintervention: −0.44 VAS, after intervention: −0.31 |
| Bradt et al. (2016)3 | MT | Chronic pain patients | n = 55 | Between-subjects | Waitlist (no music received at time of study) | Subjective | Intensity, interference, and self-efficacy | Westhaven-Yale Multidimensional Pain Inventory (MPI), Pain Self-Efficacy Questionnaire (PSEQ), NRS | MPI: −0.08, −0.24‡ NRS: −0.61, −0.27‡ |
| Gutgsell et al. (2013)24 | MT | Hospital inpatients | n = 200 | Between-subjects | Standard care alone | Subjective | Intensity | NRS, Functional Pain Scale | NRS: −0.69 “Change Score” from baseline |
| Madson et al. (2010)54 | MT | Solid organ transplant pain patients | n = 58 | Within-subjects | Pre-test/post-test design | Subjective | Intensity | 10-Point Likert-type scales | −0.30§ |
| Ames et al. (2017)2 | MM | Postoperative pain patients | n = 41 | Between-subjects | Controlled non–music listening | Subjective | Intensity | VAS, NRS, and opiate intake | VAS: −0.12║ NRS: 0.00║ Opioid intake, IV: 0.30 Opioid intake, epidural: 0.26 |
| Chan et al. (2007)7 | MM | Interventional pain patients (C-clamp procedure) | n = 66 | Between-subjects | 45-min uninterrupted rest period | Subjective and objective | Intensity | Systolic and diastolic pressure (SBP and DBP), HR, respiratory rate (RR), OS, and UCLA Universal Pain Assessment Tool | UCLA Universal Pain Assessment, MT vs control at 45-min timepoint: −1.37 |
| Chantawong et al. (2017)8 | MM | Patients undergoing loop electrosurgical excision procedure (LEEP) | n = 150 | Between-subjects | No music listening during procedure | Subjective | Intensity (pain, anxiety, and satisfaction) | VAS | VAS, pain score difference from baseline: −0.26 |
| Dobek et al. (2014)12 | MM | Healthy participants | n = 12 | Within-subjects | No music during painful stimulus | Subjective and objective | Intensity | fMRI, State-Trait Anxiety Inventory (STAI), Crowne-Marlowe Social Desirability Scale, PCS, TSA | Average pain rating: −2.21 Maximum pain rating: −2.57 |
| Garza-Villarreal et al. (2015)17 | MM | Fibromyalgia patients | n = 22 | Within-subjects | Pink noise | Subjective, objective | Intensity | PCS, fMRI | Missing data |
| Guetin et al. (2012)22 | MM | Lumbar pain, fibromyalgia, inflammatory disease, and neurological disease patients | n = 87 | Between-subjects | Standard treatment only | Subjective | Intensity | VAS | VAS at day 60: −0.79 |
| Jafari et al. (2012)36 | MM | Post–cardiac surgery patients | n = 60 | Between-subjects | No music | Subjective | Intensity | NRS | Intensity directly after intervention: −0.64 Intensity 30 minutes after intervention: −0.91 Intensity 1 h after intervention: −0.96 |
| Karalar et al. (2016)42 | MM | Renal calculi pain patients | n = 89 | Between-subjects | No headphones or music or music without noise canceling headphones | Subjective | Intensity | VAS | Music+/headphones+vs music–/headphones–: −1.23 music+/headphones+vs music+/headphones–: −0.63 |
| McCaffrey et al. (2003)57 | MM | Chronic osteoarthritis pain patients | n = 66 | Between-subjects | No music listening (quiet sitting) | Subjective | Intensity | Short Form McGill Pain Questionnaire (Pain Rating Index, VAS) | PRI: 1.64¶ VAS: 2.05¶ |
| McCaffrey et al. (2006)58 | MM | After hip or knee surgery | n = 124 | Between-subjects | Standard postoperative care | Subjective, objective | Intensity | Pain medication intake, NRS | Pain rating, average of days 1-3: −1.12 Pain medications administered: −0.31 |
| Meeuse et al. (2010)59 | MM | Interventional pain (sigmoidoscopy) | n = 307 | Between-subjects | Standard of care | Subjective | Intensity | VAS | −0.122 |
| Mercadie et al. (2015)61 | MM | Fibromyalgia patients | n = 81 | Between-subjects | Environmental sounds | Subjective | Intensity | VAS | Active situations, music vs sound: −0.02# Passive situations, music vs sound: 0# |
| Mitchell et al. (2006)62 | MM | Healthy participants | n = 54 | Within-subjects | White noise | Subjective and objective | Intensity, tolerance, and perceived control | VAS, pain rating index of the McGill Pain Questionnaire | Pain intensity (VAS): Relaxing music vs white noise: −0.340; preferred music vs white noise: −0.760; relaxing music vs preferred music: −0.431 |
| Nilsson et al. (2005)64 | MM | Open hernia repair pain patients | n = 75 | Between-subjects | Silence | Subjective, objective | Intensity | Cortisol, blood glucose, immunoglobin A levels, BP, HR, OS, and NRS | Pain NRS; intraoperative MT vs control: −0.74; postoperative MT vs control: −0.97 |
| Onieva-Zafra et al. (2013)65 | MM | Fibromyalgia patients | n = 55 | Between-subjects | No music listening | Subjective | Sensory, affective, evaluative, and intensity | McGill Pain Questionnaire Long Form, VAS | VAS after 4 wk: −1.67 |
| Özer et al. (2013)67 | MM | Open heart surgery pain patients | n = 87 | Between-subjects | Standard of care | Subjective and objective | Intensity | BP, HR, OS, RR, and unidimensional verbal pain intensity scale | Post-test pain (verbal pain intensity scale): −2.16 |
| Schneider et al. (2018)76 | MM | Postoperative (orthopedic) pain | n = 42 (n = 65 for pain logs collected, as several patients completed the exercise multiple times) | Within-subjects | Pre–post intervention pain scores | Subjective | Intensity | NRS | −0.69 |
| Shabandokht-Zarmi et al. (2017)77 | MM | Hemodialysis patients, during fistula puncture | n = 114 | Between-subjects | Headphone (no music) or control (no intervention) | Subjective | Intensity | VAS | Music vs control: 1.87**; Music vs headphone-only: 1.96** |
| Vaajoki et al. (2012)82 | MM | Laparotomy recovery | n = 168 | Between-subjects | No music listening | Objective | n/a | Analgesic use, length of hospital stay, and adverse events | Missing data |
| Villarreal et al. (2012)83 | MM | LHealthy participants | n = 48 | Between-subjects | Environmental sounds, noise | Subjective | Intensity | VAS | Missing data |
| Yeo et al. (2013)88 | MM | Cystoscopy related pain patients | n = 70 | Between-subjects | No music during procedure | Subjective | Intensity | VAS, physiological functions (hemodynamic values; mean arterial pressure; heart and respiration rates) | VAS: −1.16 |
Negative values for Hedges’ g indicate a higher value in the control group than in the treatment group. For measures evaluating pain, a negative Hedges’ g reflects a decrease in the treatment compared with the control group. For measures evaluating measures such as threshold, a negative Hedges’ g value indicates a higher pain threshold in controls compared with the treatment group. Hedges’ g: ∣0.2∣ = small effect size; ∣0.5∣ = medium effect size; ∣0.8∣ = large effect size.
“subjective” indicating measurements based on subjects’ self-reported perceptions of their experience; “objective” indicating measurements independent of subject bias. Missing data = case studies or studies in which mean and/or SD were not reported.
Hedges’ g: (mean [tx grp] – mean [control grp])/(combined SD).
(Week 8, follow-up)—data taken from “Change Score” from baseline.
Comparison between pre-MT and post-MT.
Average of 4 time-points.
Average of 3 time-points, reflecting change in pain level (D1, D7, and D14).
Average of 3 time-points.
Calculated using pain score difference before and after intervention.
Using log10-transformed times.
subjects stratified based on “worst pain” in the no VR condition.
fMRI, functional magnetic resonance imaging; VR, virtual reality.